BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37532916)

  • 1. Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status.
    Lin J; Shriver CD; Zhu K
    Cancer Causes Control; 2024 Jan; 35(1):21-31. PubMed ID: 37532916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry.
    Flanary JT; Lin J; Shriver CD; Zhu K
    Cancer Med; 2023 Nov; 12(22):20989-21000. PubMed ID: 37902129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
    Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
    Lin J; Hu H; Shriver CD; Zhu K
    Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
    Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
    Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
    Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
    Lin J; McGlynn KA; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
    Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
    Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
    Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
    Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
    Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
    Anderson AB; Kim E; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
    J Am Acad Orthop Surg; 2024 Jul; 32(13):e651-e660. PubMed ID: 38684126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
    Anderson AB; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
    J Am Acad Orthop Surg Glob Res Rev; 2022 Jun; 6(6):. PubMed ID: 35727910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.
    Inverso G; Mahal BA; Aizer AA; Donoff RB; Chuang SK
    J Oral Maxillofac Surg; 2016 Jun; 74(6):1241-7. PubMed ID: 26851312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER.
    Lin J; Orestes MI; Shriver CD; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):426-434. PubMed ID: 38099827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of health insurance on childhood cancer survival in the United States.
    Lee JM; Wang X; Ojha RP; Johnson KJ
    Cancer; 2017 Dec; 123(24):4878-4885. PubMed ID: 28891067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
    Malik AT; Alexander J; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance Status Effect on Laryngeal Cancer Survival: A Population Based Study.
    Abt NB; Miller LE; Parikh A; Bhattacharyya N
    Ann Otol Rhinol Laryngol; 2022 Jul; 131(7):775-781. PubMed ID: 34486418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of individual-level income predicted from the BRFSS on the association between insurance status and overall survival among adults with cancer from the SEER program.
    Barnes JM; Johnson KJ; Osazuwa-Peters N; Spraker MB
    Cancer Epidemiol; 2024 Apr; 89():102541. PubMed ID: 38325026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Insurance Status on Stage, Treatment, and Survival in Patients with Colorectal Cancer: A Population-Based Analysis.
    Sun W; Cheng M; Zhuang S; Qiu Z
    Med Sci Monit; 2019 Apr; 25():2397-2418. PubMed ID: 30939127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.